As Neutra Corp. (OTCBB: NTRR) works to deliver new innovations making medical marijuana (MMJ) safer and more effective than ever before, the market for such breakthroughs is expanding rapidly. Just last month, two new state legislatures—Pennsylvania and Alabama—saw favorable cannabis bills formally introduced.
“Our company is working to make sure the citizens of these states have access to the best, most effective cannabinoid medications ever developed.”
Sen. Daylin Leach of Pennsylvania and Rep. Patricia Todd of Alabama both introduced bill in their respective legislative bodies that could open up potentially lucrative new territory for MMJ innovations. While the future of the drug remains undecided in both states, NTRR executives say that public and legislative support for MMJ is clearly gaining momentum across the country.
"More and more states are choosing to end a prohibition policy that has been destructive, costly and anti-scientific," said NTRR CEO Sydney Jim. "Our company is working to make sure the citizens of these states have access to the best, most effective cannabinoid medications ever developed."
NTRR is working fast to capture a share of a growing marketplace. The emergence of several new markets—including Colorado and Washington—and continued overall growth in medical demand could boost overall MMJ sales to $3 billion in 2014 and $6 billion by 2018.
By providing innovative products and services related to MMJ, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA) and Terra Tech Corp. (PINK: TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.